Table 2.
Display of the number (%) of subjects according to qualitative data and arithmetic mean ± SD and quantitative data in relation to the examined groups (subjects after SARS-CoV-2 infection and subjects of the control group).
| Subject Groups | ||||
|---|---|---|---|---|
| after SARS-CoV-2 Infection | Control Group | p | ||
| gender | Male | 16 (64) | 17 (68) | 0.765 * |
| Female | 9 (36) | 8 (32) | ||
| diabetes | 4 (16) | 3 (12) | ||
| hypertension | 3 (12) | 1 (4) | ||
| hyperlipidemia | 1 (4) | 0 (0) | ||
| alcohol | 1 (4) | 1 (4) | ||
| smoking | 4 (16) | 3 (12) | ||
| age (years) | 46.6 ± 8.5 | 45.7 ± 7.4 | 0.699 ** | |
| BMI (kg/m2) | 25.6 ± 2.9 | 25 ± 2.8 | 0.477 ** | |
| RR systolic (mmHg) | 126.7 ± 11.6 | 120.8 ± 13.1 | 0.099 ** | |
| RR diastolic (mmHg) | 78.4 ± 9.6 | 74.6 ± 7.9 | 0.129 ** | |
| Physical activity (minutes per week of moderate activity) | 179.3 ± 25 | 182 ± 15 | 0.639 ** | |
* χ2 test; ** T test.